These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33212847)

  • 1. I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets.
    Januskaite P; Xu X; Ranmal SR; Gaisford S; Basit AW; Tuleu C; Goyanes A
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33212847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient acceptability of 3D printed medicines.
    Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
    Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations.
    Boniatti J; Januskaite P; Fonseca LBD; Viçosa AL; Amendoeira FC; Tuleu C; Basit AW; Goyanes A; Ré MI
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron.
    Allahham N; Fina F; Marcuta C; Kraschew L; Mohr W; Gaisford S; Basit AW; Goyanes A
    Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 32019101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabricating 3D printed orally disintegrating printlets using selective laser sintering.
    Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW
    Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular chemistry enables vat photopolymerization 3D printing of novel water-soluble tablets.
    Ong JJ; Chow YL; Gaisford S; Cook MT; Swift T; Telford R; Rimmer S; Qin Y; Mai Y; Goyanes A; Basit AW
    Int J Pharm; 2023 Aug; 643():123286. PubMed ID: 37532009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data.
    Seoane-Viaño I; Pérez-Ramos T; Liu J; Januskaite P; Guerra-Baamonde E; González-Ramírez J; Vázquez-Caruncho M; Basit AW; Goyanes A
    J Control Release; 2024 Jan; 365():348-357. PubMed ID: 37972762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Composite, Reinforced, Highly Drug-Loaded Pharmaceutical Printlets Manufactured by Selective Laser Sintering-In Search of Relevant Excipients for Pharmaceutical 3D Printing.
    Kulinowski P; Malczewski P; Łaszcz M; Baran E; Milanowski B; Kuprianowicz M; Dorożyński P
    Materials (Basel); 2022 Mar; 15(6):. PubMed ID: 35329594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
    Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D Printing of Tunable Zero-Order Release Printlets.
    Fina F; Goyanes A; Rowland M; Gaisford S; W Basit A
    Polymers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case study on decentralized manufacturing of 3D printed medicines.
    Seoane-Viaño I; Xu X; Ong JJ; Teyeb A; Gaisford S; Campos-Álvarez A; Stulz A; Marcuta C; Kraschew L; Mohr W; Basit AW; Goyanes A
    Int J Pharm X; 2023 Dec; 5():100184. PubMed ID: 37396623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A micro-extrusion 3D printing platform for fabrication of orodispersible printlets for pediatric use.
    Eduardo DT; Ana SE; José B F
    Int J Pharm; 2021 Aug; 605():120854. PubMed ID: 34224841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process.
    Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW
    Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders.
    Rodríguez-Pombo L; de Castro-López MJ; Sánchez-Pintos P; Giraldez-Montero JM; Januskaite P; Duran-Piñeiro G; Dolores Bóveda M; Alvarez-Lorenzo C; Basit AW; Goyanes A; Couce ML
    Int J Pharm; 2024 May; 657():124140. PubMed ID: 38643809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D printing of drug-loaded gyroid lattices using selective laser sintering.
    Fina F; Goyanes A; Madla CM; Awad A; Trenfield SJ; Kuek JM; Patel P; Gaisford S; Basit AW
    Int J Pharm; 2018 Aug; 547(1-2):44-52. PubMed ID: 29787894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser sintering (SLS) 3D printing of medicines.
    Fina F; Goyanes A; Gaisford S; Basit AW
    Int J Pharm; 2017 Aug; 529(1-2):285-293. PubMed ID: 28668582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks.
    Trenfield SJ; Xian Tan H; Awad A; Buanz A; Gaisford S; Basit AW; Goyanes A
    Int J Pharm; 2019 Aug; 567():118443. PubMed ID: 31212052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems.
    Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
    Pharm Res; 2018 Nov; 36(1):4. PubMed ID: 30406349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.